rs1555873356
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001849.4(COL6A2):c.1000-2A>C variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001849.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.1000-2A>C | splice_acceptor_variant, intron_variant | Intron 10 of 27 | ENST00000300527.9 | NP_001840.3 | ||
COL6A2 | NM_058174.3 | c.1000-2A>C | splice_acceptor_variant, intron_variant | Intron 10 of 27 | NP_478054.2 | |||
COL6A2 | NM_058175.3 | c.1000-2A>C | splice_acceptor_variant, intron_variant | Intron 10 of 27 | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.1000-2A>C | splice_acceptor_variant, intron_variant | Intron 10 of 27 | 1 | NM_001849.4 | ENSP00000300527.4 | |||
COL6A2 | ENST00000397763.6 | c.1000-2A>C | splice_acceptor_variant, intron_variant | Intron 10 of 27 | 5 | ENSP00000380870.1 | ||||
COL6A2 | ENST00000409416.6 | c.1000-2A>C | splice_acceptor_variant, intron_variant | Intron 9 of 26 | 5 | ENSP00000387115.1 | ||||
COL6A2 | ENST00000485591.1 | n.656-2A>C | splice_acceptor_variant, intron_variant | Intron 6 of 6 | 3 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
The c.1000-2 A>C splice site variant in the COL6A2 gene destroys the canonical splice acceptor site for intron 10. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. This splice site variant occurs within the the triple helical (TH) domain of collagen VI, a region that is well-conserved across species. Additionally, this variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.1000-2 A>C as a pathogenic variant. -
Bethlem myopathy 1A Pathogenic:1
This sequence change affects an acceptor splice site in intron 10 of the COL6A2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COL6A2 are known to be disease-causing for autosomal recessive COL6A2-related conditions (PMID: 21280092, 20976770). However, certain variants affecting donor or acceptor splice sites in the triple helical domain of COL6A2 are expected to result in in-frame exon skipping and have been reported to cause autosomal dominant COL6A2-related conditions (PMID: 18366090). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with autosomal dominant COL6A2-related conditions (PMID: 17886299; Invitae). ClinVar contains an entry for this variant (Variation ID: 476446). Studies have shown that disruption of this splice site is associated with altered splicing resulting in multiple RNA products (PMID: 17886299). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at